| scholarly article | Q13442814 |
| P2093 | author name string | J. H. Griffin | |
| R. A. Houghten | |||
| R. M. Mesters | |||
| P2860 | cites work | Characterization of a cDNA coding for human factor X | Q24595573 |
| Deficiency of protein C in congenital thrombotic disease | Q24600822 | ||
| General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids | Q24612820 | ||
| The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs | Q24626095 | ||
| THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS | Q26778400 | ||
| A comprehensive set of sequence analysis programs for the VAX | Q26778432 | ||
| A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S | Q28262397 | ||
| Characterization of a cDNA coding for human factor VII | Q28646329 | ||
| Anticoagulant properties of bovine plasma protein C following activation by thrombin | Q34241254 | ||
| Molecular cloning of the gene for human anti-haemophilic factor IX. | Q34253608 | ||
| Preparation and properties of bovine factor VIII (antihemophilic factor). | Q34285283 | ||
| Topographical localization of the C-terminal region of the voltage-dependent sodium channel from Electrophorus electricus using antibodies raised against a synthetic peptide | Q34587067 | ||
| Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. | Q35345503 | ||
| Evolution and organization of the human protein C gene | Q35587591 | ||
| Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin | Q36597580 | ||
| Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin | Q37041393 | ||
| Intrinsic and extrinsic factors in protein antigenic structure | Q38151120 | ||
| The physical basis for induction of protein-reactive antipeptide antibodies | Q38190293 | ||
| Location of disulphide bridges by diagonal paper electrophoresis. The disulphide bridges of bovine chymotrypsinogen A. | Q39254503 | ||
| Vitamin K-Dependent Formation of γ-Carboxyglutamic Acid | Q39687153 | ||
| Molar absorptivity and A1 percent 1cm values for proteins at selected wavelengths of the ultraviolet and visible regions. IX. | Q39934344 | ||
| The evolutionary relationship of the enzymes involved in blood coagulation and hemostasis | Q42077532 | ||
| Comparative modeling methods: application to the family of the mammalian serine proteases | Q43524110 | ||
| Mutations in the catalytic domain of human coagulation factor IX: rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior | Q45884668 | ||
| Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant | Q59418581 | ||
| The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V | Q66971115 | ||
| Interaction of vitamin K dependent proteins with membranes | Q67015739 | ||
| Immunoblotting studies of the molecular forms of protein C in plasma | Q67985678 | ||
| Proteolytic formation and properties of a fragment of protein C containing the gamma-carboxyglutamic acid rich domain and the EGF-like region | Q68780218 | ||
| Comparison of four bifunctional reagents for coupling peptides to proteins and the effect of the three moieties on the immunogenicity of the conjugates | Q69205718 | ||
| A fatal thrombotic disorder associated with an acquired inhibitor of protein C | Q69453345 | ||
| One-step procedure for the rapid isolation of mouse monoclonal antibodies and their antigen binding fragments by fast protein liquid chromatography on a mono Q anion-exchange column | Q70060990 | ||
| Comparative model-building of the mammalian serine proteases | Q70240611 | ||
| Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn | Q70811173 | ||
| p-Nitrophenyl-p'-guanidinobenzoate HCl: a new active site titrant for trypsin | Q82640878 | ||
| P433 | issue | 36 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biochemistry | Q7094 |
| cell biology | Q7141 | ||
| blood coagulation | Q179217 | ||
| anticoagulant | Q215118 | ||
| drotrecogin alfa | Q412888 | ||
| anticoagulation | Q63279445 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 24514-24519 | |
| P577 | publication date | 1991-12-01 | |
| 1991-12-25 | |||
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Identification of a sequence of human activated protein C (residues 390-404) essential for its anticoagulant activity | |
| P478 | volume | 266 |
| Q36280112 | Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va. |
| Q39026107 | Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor V. |
| Q41771533 | Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va. |
| Q41786857 | Function of the activated protein C (APC) autolysis loop in activated FVIII inactivation |
| Q45827359 | Identification of protein C epitopes altered during its nanoencapsulation |
| Q50924464 | Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIa. |
| Q34165592 | Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant |
| Q36278184 | Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C. |
| Q38269759 | Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C |
| Q36278723 | Models of the serine protease domain of the human antithrombotic plasma factor activated protein C and its zymogen |
| Q41142483 | Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va |
| Q36863328 | Safety, Stability and Pharmacokinetic Properties of (super)Factor Va, a Novel Engineered Coagulation Factor V for Treatment of Severe Bleeding. |
| Q27734660 | The 2.8 A crystal structure of Gla-domainless activated protein C |
Search more.